Trandolapril and Fenofibrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trandolapril (trandolapril) and Fenofibrate (fenofibrate). Common drug interactions include oedema peripheral among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Trandolapril and Fenofibrate. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Trandolapril?

Trandolapril has active ingredients of trandolapril. It is often used in high blood pressure. eHealthMe is studying from 2,682 Trandolapril users. Check the latest studies of Trandolapril.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

38 people who take Trandolapril and Fenofibrate together, and have interactions are studied.

Trandolapril and Fenofibrate drug interactions.

What are the common drug interactions of Trandolapril and Fenofibrate, by gender? *:

female:

Oedema peripheral (superficial swelling)
Concussion (short loss of normal brain function in response to a head injury)
Syncope (loss of consciousness with an inability to maintain postural tone)
Abasia (inability to walk)
Adverse drug reaction
Anxiety
Chest pain
Chills (felling of cold)
Chronic kidney disease
Clostridium test positive

male:

Asthenia (weakness)
Fall
Haemodynamic instability (disturbances in the blood movement in our body)
Multi-organ failure (multisystem organ failure)
Pneumonia
Pyrexia (fever)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Abdominal discomfort
Acute myocardial infarction (acute heart attack)
Arterial occlusion (blockage of a blood vessel, usually with a clot)

What are the common drug interactions of Trandolapril and Fenofibrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Cytomegalovirus colitis (an inflammation of the colon from virus)
Drug resistance (reduction in effectiveness of a drug)

50-59:

Chills (felling of cold)
Abdominal discomfort
Adverse drug reaction
Anxiety
Completed suicide (act of taking one's own life)
Cough
Disease progression
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Nasopharyngitis (inflammation of the nasopharynx)

60+:

Oedema peripheral (superficial swelling)
Asthenia (weakness)
Pancreatitis acute (sudden inflammation of pancreas)
Pneumonia
Renal impairment (severely reduced kidney function)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Abasia (inability to walk)
Acute myocardial infarction (acute heart attack)
Arterial occlusion (blockage of a blood vessel, usually with a clot)
Arterial stenosis (abnormal narrowing of the aortic valve in the heart)

What are the existing conditions these people have? *

Type 2 Diabetes: 7 people, 18.42%
Dyslipidaemia (abnormal amount of lipids): 5 people, 13.16%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 10.53%
Pain: 3 people, 7.89%
Diabetes: 3 people, 7.89%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 5.26%
Multiple Myeloma (cancer of the plasma cells): 2 people, 5.26%
Low Density Lipoprotein Increased (cholesterol increased in blood): 2 people, 5.26%
Immunodeficiency Common Variable: 2 people, 5.26%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Trandolapril and Fenofibrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously